Insiders who reported open-market trades in the last 12 months at the companies Bihua Chen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
ORBIMED ADVISORS LLC - $10.00M in BLSM purchases and sales in the last 12 months
Carl L. Gordon - $10.00M in BLSM purchases and sales in the last 12 months
John P. Schmid - $96K in BLSM purchases and sales in the last 12 months
Vincent Paul Liptak - $75K in BLSM purchases and sales in the last 12 months
Jason A. Keyes - $11K in BLSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Bihua Chen is a corporate insider, tracked as Director, 10% Owner of BlossomHill Therapeutics, Inc. (BLSM). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Bihua Chen submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Bihua Chen been buying or selling stock?
Recorded transactions: 2 open-market purchases ($13.00M) and 5 open-market sales ($46.87M) across all tracked filings.
Bihua Chen is Director, 10% Owner of BlossomHill Therapeutics, Inc. (BLSM). 8 SEC Form 4 filings on record going back to 2025, most recently on 10 August 2026. Most recent open-market trade: bought $5.00M of BLSM on 10 August 2026. Lifetime open-market purchases: $13.00M. Lifetime open-market sales: $46.87M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Bihua Chen.
InsiderAlpha's records for Bihua Chen go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $6.50M (2 buys totaling $13.00M). The largest single buy on record is $8.00M of HLXC in 2026. Sales side: 5 recorded sales totaling $46.87M, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
